InvestorsHub Logo
Followers 31
Posts 7695
Boards Moderated 0
Alias Born 01/24/2007

Re: Dunderstand post# 57213

Wednesday, 07/08/2020 12:35:38 PM

Wednesday, July 08, 2020 12:35:38 PM

Post# of 59549
You can buy as much as you want. Plenty of supply of cheap shares as their converted debt floods the market.

It’s unbelievable anyone would tout a stock that is wildly unprofitable even with a claimed disruptive product. Especially since it’s previous incarnation did primarily the same thing. Maybe it’s the lack of transparency on the underlying patents or cloudy licensing arrangement that is floated but never appears in any disclosures. The question remains:

1. Do they own the patent on this delivery system?
2. Do they have a US exclusive licensing deal with the pharma that’s owns the patent?

I think it’s safe to say none of these points are true for GPFT. So at best they would be one of a thousand cannabis companies that is just authorized to sell it. Since they are poorly capitalized and leverage to a property that will be months if not a year to complete. Given that I don’t see how this company is worth anywhere near 12M.